09-05-2025 17:27 via drugs.com

Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting

FRIDAY, May 9, 2025-- The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of aflibercept than in clinical trials, according to a study published online May 1 in JAMA...

Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults

Three New Color Food Additives From Natural Sources Approved by FDA

FDA Warns of Possible Bacteria Contamination of Tattoo Inks

Multicancer Early Detection Screening Improves Patient Outcomes

Women Have Higher Risk for COPD Than Men, Regardless of Smoking History

Computer-Aided Design and Manufacturing Assists Jaw Reconstruction

Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24

Guidelines Updated for Nonoccupational Postexposure Prophylaxis for HIV

No Negative Psychological Impact Seen for Disclosing Aβ Status

Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial

Trump Taps Wellness Influencer Casey Means for Surgeon General

Thinking About a Tattoo? FDA Warns These Inks Could Be Dangerous

Some Cancers Increasing in People Under 50, New Report Shows

Childhood Obesity Triples Odds Of Weight Discrimination

Desktop versie

Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting

Pharmaceutical news